Newsitem on Standard Imaging W2
Gamechanging technology for Stereotactic/ Small field Dosimetry by eliminating all corrections factors. Simplify your SRS/SRT QA protocols (existing TRS 483) and gain accuracy on your output factors Recently Standard Imaging released their new Exradin W2 Scintillator, which is the only device on the market that is both completely water …
Newsitem on RT-Safe
Personalize your stereotactic quality assurance solutions with a PseudoPatient™ and improve your end to end QA. RTsafe is providing innovative, 3D printed pseudo in-vivo phantoms and remote dosimetry services. Their solutions will provide cancer centers an elegant quality assurance (QA) solution by elevating confidence in the end-to-end accuracy of stereotactic …
Newsitem on Gold Anchor
Groundbraking publication on randomized trial on ultra-hypofractionated radiotherapy, the HYPO-RT-PC phase 3! Fiducial markers will become even more important when applying ultra-hypofractionated radiotherapy for prostate cancer. Congratulations to all the 12 Swedish and Danish centers that have contributed to the HYPO-RT-PC phase 3 trial! As the first published randomized …